180N logo

Norwegian Nuclear Medicine Consortium

A bright spot in the fight against prostate cancer

With the relatively new imaging method PET/MR, we can ‘see’ the cancer much earlier – and perhaps more clearly.

Read More
PET images of glioblastom

Illuminating brain tumours with radioactive sniffer dogs

Bringing light into the darkness of the brain by using radioactive molecules acting as “sniffer…

Read More

180°N Autumn Webinar 2021

Welcome to our webinar October 1st 2021 09:00-11:30!

Read More...

Travel Grants

The following travel grants can be applied for:  A) Research stays abroad or within Norway for project participants B) Incoming…

Read More...
Webinar illustration

1st 180N Spring Webinar 2021

Join us for the first webinar with updates and results from the ongoing consortium projects! Time: May 7th 10:00 –…

Read More...

180°N Conference Tromsø

The conference is open to all people interested in the field of nuclear medicine, and active participation from projects under…

Read More...

About 180°N

The overarching aim of the 180°N (Norwegian Nuclear Medicine Consortium) project is to strengthen research in nuclear medicine connected to the nuclear medicine equipment donated by Trond Mohn Foundation and Tromsø Research Foundation to the universities and hospitals in Trondheim, Tromsø and Bergen.

Founders

Partners